Skip to content

Category: In the News

NY Times- Mammograms’ Value in Cancer Fight at Issue

By GINA KOLATA, A new study suggests that increased awareness and improved treatments rather than mammograms are the main force in reducing the breast cancer death rate.   Starting in their 40s or 50s, most women in this country faithfully get a mammogram every year, as recommended by health officials. But the study suggests that…

NY Times- Mammograms’ Value in Cancer Fight at Issue

By GINA KOLATA, A new study suggests that increased awareness and improved treatments rather than mammograms are the main force in reducing the breast cancer death rate.   Starting in their 40s or 50s, most women in this country faithfully get a mammogram every year, as recommended by health officials. But the study suggests that…

New York Times- New Drugs Stir Debate on Basic Rules of Clinical Trials

By AMY HARMON, Growing up in California’s rural Central Valley, the two cousins spent summers racing dirt bikes and C hristmases at their grandmother’s on the coast. Endowed with a similar brash charm, they bought each other matching hardhats and sought iron-working jobs together. They shared a love for the rush that comes with hanging…

NY Times- Is Newer Better? Not Always

Editorial, The Congressional Budget Office estimates that an astonishing half or more of the increased spending for health care  in recent decades is due to technological, surgical and clinical advances.      For the most part, such advances are a cause for celebration. But an expensive new drug is not always better than an older, cheaper…

NY Times- Is Newer Better? Not Always

Editorial, The Congressional Budget Office estimates that an astonishing half or more of the increased spending for health care  in recent decades is due to technological, surgical and clinical advances.      For the most part, such advances are a cause for celebration. But an expensive new drug is not always better than an older, cheaper…

AP- Appeals court allows stem cell funding for now

By PETE YOST, WASHINGTON — A federal appeals court on Thursday permitted federal funding of stem cell research to proceed for now , while it considers a judge’s ruling that had temporarily shut off the funds. The government is asking the appeals court in Washington to strike down a preliminary order by U.S. District Judge…

AP- Appeals court allows stem cell funding for now

By PETE YOST, WASHINGTON — A federal appeals court on Thursday permitted federal funding of stem cell research to proceed for now , while it considers a judge’s ruling that had temporarily shut off the funds. The government is asking the appeals court in Washington to strike down a preliminary order by U.S. District Judge…

Reuters- Obama administration appeals stem cell injunction

By Jeremy Pelofsky WASHINGTON (Reuters) – The Obama administration asked a federal judge on Tuesday to lift an injunction halting human  embryonic stem cell research, saying it would irreparably harm research and cost more than 1,300 jobs. The Justice Department also appealed against the injunction by Judge Royce Lamberth in which he ruled National Institutes…

Washington Post- NIH cuts off stem cell funding after court order

By Rob Stein,   The National Institutes of Health announced Tuesday that it has suspended funding  new human embryonic stem cell research and that all federally funded experiments already underway will be cut off when they come up for renewal if a new court order is not overturned. The announcement – which confirmed fears among…

Reuters- U.S. court rules against Obama's stem cell policy

Ruling could stop NIH stem cell funding (cancer research), Judge says even paying for research harms embryos By Jeremy Pelofsky and Maggie Fox WASHINGTON, Aug 23 (Reuters) – A U.S. district court issued a preliminary injunction on Monday stopping federal funding of human embryonic stem cell research, in a slap to the Obama administration’s new…